StandardX raises £10 million seed to build an isotope refinery
Its £10m Seed financing will support the team, a London industrial site and the first accelerator-based isotope refinery.
StandardX announced a £10 million Seed round on 23 September 2026, co-led by Vsquared Ventures and East X Ventures. The financing supports its first accelerator-based isotope refinery.
A single platform for isotope production
StandardX is developing an accelerator-based production system intended to make a range of isotopes from one industrial footprint. The company aims to supply materials for cancer diagnosis and treatment, where current production capacity is limited, and for industrial uses that depend on reliable isotope supply.
Starting with medical isotopes
The seed capital will support the company’s first medical isotope production and the build-out of its refinery. StandardX says it plans to supply its first isotopes to a medical research partner in 2027. Vsquared Ventures and East X Ventures co-led the round, with firstminute capital, UKI2S, Brevan Howard Macro Venture and Geometry participating.
Use of funds
Grow the team, secure an industrial site in London and build the first accelerator-based isotope refinery.